Fig. 4: Overall survival (OS) from the time of relapse.
Outcome for patients with pretreatment in the sorafenib arm (red line) or placebo arm (black line).
Fig. 4: Overall survival (OS) from the time of relapse. | Leukemia
Outcome for patients with pretreatment in the sorafenib arm (red line) or placebo arm (black line).
